Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia

Journal of Clinical Microbiology

Volumn 38, Issue 8, 2000, Pages 3055-3060

  Wunschmann, S ^a   Stapleton, J T ^a  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CELL FUSION; CELL SIZE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; SYNCYTIUM; VIRUS INHIBITION;

EID: 0033876130     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.8.3055-3060.2000     Document Type: Article

References (32)

1. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
2. Immunoflourescence and cell sorting: Use of flow cytometry for DNA analysis
3. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
4. Modulation of human immunodeficiency virus type-1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay
5. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates
6. A new classification for HIV-1
7. CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo
8. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
9. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
10. Effect of a single ethanol ingestion on lymphocyte subsets and in vitro HIV replication
11. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection
12. Chemokines and HIV-1 second receptors
13. Host factors and the pathogenesis of HIV-induced disease
14. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
15. Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T cell-tropic HIV-1 by three different monoclonal antibodies
16. Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates
17. Detection and quantitation of cell-cell electrofusion products by flow cytometry
18. Inhibition of HIV type 1 infectivity by constrained α-helical peptides: Implications for the viral fusion mechanism
19. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay
20. Prevalence of HIV-1 syncytium-inducing phenotype
21. HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients
22. Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus
23. HIV pathogenesis and long-term survival
24. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
25. Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay
26. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro
27. + cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry
28. + cells following their fusion with HIV-infected cells
29. HIV-induced syncytia are self-perpetuating and the primary cause of T cell death in culture
30. Evolution of syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection
31. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs
32. Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons